亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

3,4,5-三咖啡酰奎寧酸 CAS:86632-03-3

 
 
單價 面議對比
詢價 暫無
發(fā)貨 四川成都市付款后3天內(nèi)
品牌 鈉鈳鋰
過期 長期有效
更新 2021-11-25 12:22
 

成都鈉鈳鋰生物科技有限公司

企業(yè)會員第5年
資料未認(rèn)證
保證金未繳納
詳細(xì)說明

nkl-00132

中文名稱:3,4,5-三咖啡酰奎寧酸
英文名稱:3,4,5-Tricaffeoylquinic acid
英文別名:Cyclohexanecarboxylic acid, 3,4,5-tris[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-1-hydroxy-, [1R-[1α,3α(E),4α(E),5β(E)]]-
CAS號:86632-03-3
純度: HPLC≥98%

分子式:C34H30O15
分子量:678.59
外觀:白色針晶粉末
沸點(diǎn): 916.0±65.0 °C | Condition
密度: 1.64±0.1 g/cm3 | Condition: Temp: 20 °C
pKa值: 3.31±0.50 | Condition: Most Acidic Temp: 25 °C
提取來源:蒼耳

規(guī)格:10mg,20mg,50mg;可根據(jù)客戶需求包裝、定制

儲存條件: 低溫,避光、干燥、密封

用途: 用于鑒別、含量測定、藥理實(shí)驗、活性篩選等科研、實(shí)驗室使用;不得直接用于人體

供應(yīng)商:成都鈉鈳鋰生物科技有限公司

舉報收藏 0評論 0
更多>本企業(yè)其它產(chǎn)品
2”-O-沒食子酰基金絲桃苷 CAS:53209-27-1 甘草酸 CAS:1405-86-3 甘草酸銨 CAS:53956-04-0 甘草查爾酮A CAS:58749-22-7 甘草查爾酮B CAS:58749-23-8 甘草查爾酮C CAS:144506-14-9 重樓皂苷II CAS:50773-42-7 重樓皂苷III CAS:19057-60-4
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |